Natus Medical Inc (NTUS) Return on Equity ROE from the first quarter 2022 to first quarter 2021 and annually, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Natus Medical Inc  (NASDAQ: NTUS)

Natus Medical Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Natus Medical Inc in the first quarter 2022?
Natus Medical Inc achieved a return on average equity (ROE) of 2.99 % in its first quarter 2022, which is below Natus Medical Inc's average return on equity, which stands at 3.78%.

ROE fell compared to the fourth quarter 2021, despite the net income growth of 9.12% from the fourth quarter 2021.

Within the Medical Equipment & Supplies industry 60 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2021 from 2457 to 2494.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Equity Change 5.37 % 3.32 % 6.84 % 5.65 % -
Y / Y Net Income Change -20.58 % -66.48 % - - -
Net Income (TTM) in Millions 13 13 17 2 -11
Return On Equity (TTM) 2.99 % 3.15 % 4.01 % 0.43 % -2.64 %
NTUS's Total Ranking # 2494 # 2457 # 2416 # 0 # 0
Equity (TTM) in Millions 431 425 423 418 409
Seq. Equity Change 1.45 % 0.53 % 1.12 % 2.18 % -0.53 %
Seq. Net Income Change 9.12 % -68.71 % 60.88 % 44.57 % -53.95 %

Back to NTUS Management Effectiveness >> NTUS's 5 Years Annual ROE >> Compare NTUS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 61
Sector # 201
Overall # 2494

Return On Equity Statistics
High Average Low
10.94 %
3.78 %
-5.63 %
(Sep 30 2015)   (Mar 31 2018)





NTUS Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Equity in Millions 425 411 416 398 422
Y / Y Equity Change 3.32 % -1.21 % 4.44 % -5.6 % 1.13 %
Net Income in Millions 13 -17 -16 -23 -20
Y / Y Net Income Change - - - - -
Return On Equity 3.1 % -4.04 % -3.77 % -5.76 % -4.81 %

Back to NTUS Management Effectiveness >> NTUS's 5 Years Annual ROE >> Compare NTUS ROE to its Competitors




Annual Roe Comment
In 2021 ROE improved to 3.1 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NTUS's' Return on Equity at Yahoo Finance
NTUS's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NTUS's Competitors
Subscribers only: Roe for Natus Medical Inc's Suppliers
Subscribers only: Return On Equity for NTUS's Customers




Companies with similar Return On Equity at Mar 31 2022, within Healthcare Sector ROE
Becton Dickinson And Company  8.00 %
Addus Homecare Corp  7.90 %
Iterum Therapeutics Plc  7.77 %
Lhc Group Inc   7.59 %
Atea Pharmaceuticals Inc   7.54 %
Illumina Inc   7.49 %
Dentsply Sirona Inc   7.36 %
Syneos Health Inc   7.30 %
Electromed Inc   7.04 %
Healthcare Services Group Inc   7.00 %
Champions Oncology Inc   6.82 %
Integer Holdings Corporation  6.46 %
Pacific Health Care Organization Inc  6.32 %
Lakeland Industries Inc   6.26 %
Bionexus Gene Lab Corp   6.10 %
Haemonetics Corporation  6.07 %
Surgery Partners Inc   5.82 %
Neogen Corporation  5.76 %
Pacira Biosciences inc   5.40 %
Neurocrine Biosciences Inc   5.30 %
Syndax Pharmaceuticals Inc   5.18 %
Boston Scientific Corporation  4.93 %
Merit Medical Systems Inc  4.68 %
Steris Plc  4.12 %
American Shared Hospital Services  4.08 %
Takeda Pharmaceutical Company Limited  4.05 %
Vanda Pharmaceuticals Inc   3.65 %
Taro Pharmaceutical Industries Ltd  3.40 %
Innovage Holding Corp   3.40 %
Assertio Holdings inc   3.21 %

Date modified: 2026-09-26T07:17:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.